Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-19

Clinical Trial Update: Exploratory Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RXLAL) With The Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism [NA]

View source ↗

Summary

Completed exploratory clinical trial evaluating uncorrected distance vision and quality of vision after light-treated, implanted Light Adjustable Lens with ligh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) (Light Adjustable Lens (RxSight LAL) with Light Delivery Device)

Snippet

Sponsor: RxSight, Inc. | Conditions: Aphakia, Cataract | NA | Status: COMPLETED | Results posted: 2021-05-19